These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 19506189)

  • 1. An objective evaluation of eyedrop instillation in patients with glaucoma.
    Stone JL; Robin AL; Novack GD; Covert DW; Cagle GD
    Arch Ophthalmol; 2009 Jun; 127(6):732-6. PubMed ID: 19506189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating eye drop instillation technique in glaucoma patients.
    Gupta R; Patil B; Shah BM; Bali SJ; Mishra SK; Dada T
    J Glaucoma; 2012 Mar; 21(3):189-92. PubMed ID: 21336146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of eye drop administration technique in patients with glaucoma or ocular hypertension.
    Schwartz GF; Hollander DA; Williams JM
    Curr Med Res Opin; 2013 Nov; 29(11):1515-22. PubMed ID: 24006861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A video study of drop instillation in both glaucoma and retina patients with visual impairment.
    Hennessy AL; Katz J; Covert D; Kelly CA; Suan EP; Speicher MA; Sund NJ; Robin AL
    Am J Ophthalmol; 2011 Dec; 152(6):982-8. PubMed ID: 21821228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Eye Drop Instillation Before and After Use of Drop Application Strips in Glaucoma Patients on Chronic Topical Therapy.
    Sharma R; Singhal D; Shashni A; Agarwal E; Wadhwani M; Dada T
    J Glaucoma; 2016 Apr; 25(4):e438-40. PubMed ID: 26550965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mirror-hat device as a drop delivery aid: a pilot study.
    Strungaru MH; Peck J; Compeau EC; Trope GE; Buys YM
    Can J Ophthalmol; 2014 Aug; 49(4):333-8. PubMed ID: 25103649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications.
    Fechtner RD; Godfrey DG; Budenz D; Stewart JA; Stewart WC; Jasek MC
    Cornea; 2010 Jun; 29(6):618-21. PubMed ID: 20386433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of eye drop instillation technique in glaucoma patients.
    Gomes BF; Paredes AF; Madeira N; Moraes HV; Santhiago MR
    Arq Bras Oftalmol; 2017; 80(4):238-241. PubMed ID: 28954024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ocular hypotensive effect of 1% carteolol long-acting eye drops--a double-masked, randomized phase III study in ocular hypertension or primary open-angle glaucoma patients comparing long-acting carteolol eye drops vs. current product].
    Yamamoto T;
    Nippon Ganka Gakkai Zasshi; 2007 Jun; 111(6):463-72. PubMed ID: 17601060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inter-Rater Agreement in the Assessment of Video Recordings of Eye Drop Instillation by Glaucoma Patients.
    Park MS; Patel MM; Sarezky D; Rojas C; Choo C; Choi M; Liu D; Rademaker AW; Tanna AP
    PLoS One; 2016; 11(1):e0145764. PubMed ID: 26730605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of eyedrop administration by inexperienced patients after cataract surgery.
    An JA; Kasner O; Samek DA; Lévesque V
    J Cataract Refract Surg; 2014 Nov; 40(11):1857-61. PubMed ID: 25248295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of adherence to brimonidine therapy for glaucoma using electronic monitoring.
    Hermann MM; Bron AM; Creuzot-Garcher CP; Diestelhorst M
    J Glaucoma; 2011 Oct; 20(8):502-8. PubMed ID: 20852438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular hypotensive effects and safety over 3 months of switching from an unfixed combination to latanoprost 0.005%/timolol maleate 0.5% fixed combination.
    Inoue K; Okayama R; Higa R; Sawada H; Wakakura M; Tomita G
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):581-7. PubMed ID: 22011049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nationwide survey of factors influencing adherence to ocular hypotensive eyedrops in Japan.
    Tsumura T; Kashiwagi K; Suzuki Y; Yoshikawa K; Suzumura H; Maeda T; Takeda R; Saito H; Araie M
    Int Ophthalmol; 2019 Feb; 39(2):375-383. PubMed ID: 29330811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Videotaped evaluation of eyedrop instillation in glaucoma patients with visual impairment or moderate to severe visual field loss.
    Hennessy AL; Katz J; Covert D; Protzko C; Robin AL
    Ophthalmology; 2010 Dec; 117(12):2345-52. PubMed ID: 20580092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study.
    Okeke CO; Quigley HA; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Friedman DS
    Ophthalmology; 2009 Feb; 116(2):191-9. PubMed ID: 19084273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of medication adherence to topical glaucoma therapy.
    Dreer LE; Girkin C; Mansberger SL
    J Glaucoma; 2012; 21(4):234-40. PubMed ID: 21623223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eye Drop Dispenser Type and Medication Possession Ratio in Patients With Glaucoma: Single-Use Containers Versus Multiple-Use Bottles.
    Na KH; Yoo C; Park JH; Kim YY
    Am J Ophthalmol; 2018 Apr; 188():9-18. PubMed ID: 29391124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xal-Ease: impact of an ocular hypotensive delivery device on ease of eyedrop administration, patient compliance, and satisfaction.
    Nordmann JP; Baudouin C; Bron A; Denis P; Rouland JF; Sellem E; Renard JP
    Eur J Ophthalmol; 2009; 19(6):949-56. PubMed ID: 19882583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of topical diclofenac sodium on the ocular hypotensive effect of latanoprost in glaucoma patients.
    Sorkhabi R; Alipanahi R; Eftakhari-Milani A; Ghojazadeh L
    J Glaucoma; 2011; 20(4):240-3. PubMed ID: 20577116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.